Levothyroxine use can cause subclinical hyperthyroidism. See if that can increase fracture risk in elderly patients. Article covers results and analysis of a thyroid study.
Reclast is an osteoporosis medication, and in September 2011, the FDA issued a new warning label for it. It may cause renal impairment, so physicians should be cautious before prescribing. Article reviews new FDA label for Reclast.
Research comparing the safety and effectiveness of oral minodronate at monthly doses of 30 mg or 50 mg to a daily dose of 1 mg in patients with osteoporosis.
Low testosterone levels are associated with increased mortality in men, and men with type 2 diabetes have a high prevalence of testosterone deficiency.
Long-term safety and efficacy data on pediatric patients treated with Norditropin® are being collected through a registry called American Norditropin Studies: Web-Enabled Research.
Are high doses of vitamin D3 better than the standard dose for boosting bone mineral density and decreasing bone turnover in post-menopausal women who have low bone mass?
In an observational cross-sectional study, researchers investigated the severity of obstructive sleep apnea (OSA) and the effect on glycemic control in patients with type 2 diabetes.
Due to the prevalence of diabetes and pre-diabetes, the USDA Dietary Guidelines strongly parallel nutritional recommendations for people living with diabetes.
The artificial pancreas concept is progressing toward reality thanks to work driven by the Juvenile Diabetes Research Foundation, FDA, and other organizations.